ArticleIndian journal of microbiology2025
Biotherapeutic Potential of Probiotic Yeast
Article in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Yeast Probiotics to Postbiotics: A Continuum Model and Yeast-Specific Functional Perspective.Cells · 2026Review
- Unraveling the Therapeutic Potential of Antifungal Metabolites ofIndian journal of microbiology · 2025Article
- Vacuole and mitochondria patch protein Mcp1 of Saccharomyces boulardii impairs the oxidative stress response of Candida albicans by regulating 2-phenylethanol.Microbial cell factories · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential of innovative and alternative probiotic-based antifungal drugs to treat severe biofilm-associated infections has increased demand in recent years. A potentially fatal systemic fungal disease, candidiasis mostly affects the skin and mucous membranes lining inside body cavities such as the nose, mouth, lips, eyes, ears, and genital area. Candida-induced biofilms are densely arranged communities with specific structures that adhere to the surfaces of embedded devices, are covered by an extracellular matrix, and act as an essential virulent factor. It is crucial to explore innovative approaches to aid in treating such fungal illnesses because conventional medications are no longer effective in treating candidiasis. Researchers have been driven to identify the triggers that cause biofilm to grow and mature due to the difficulties involved with biofilm-related disorders. There are still several challenges in Candidasis disease management in clinical settings. A potentially effective approach involves utilising probiotic microorganisms and/or their metabolites, including probiotic yeast
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.